Molecular gradients are common in biosystems and play an essential role in physiological and pathological processes. During carcinogenesis, for example, hyaluronan (HA) homeostasis is dysregulated by cancer cells and the altered synthesis and degradation processes result in the formation of HA gradients within the tumor microenvironment. Herein, a platform is developed to study the biological role of HA gradient in breast cancer cells. Cells with different aggressiveness and expression of CD44-the main HA receptor usually overexpressed in breast cancers, are selected for this study. The developed platform is compatible with several imaging modalities and allows assessment of cell density, morphology, CD44 expression, and cell motility in a function of HA density. Using high-throughput analysis, it is shown that cells that do not express CD44 do not change along the gradient, while CD44 positive cells respond differently to the HA gradient depending on the level of CD44 expression and HA density. This different response is associated with the activation of different signaling pathways by the CD44-HA interactions.
IntroductionCancer development, progression, and recurrence rely on bidirectional communication between cancer cells and the extracellular matrix (ECM). [1] This communication results in ECM remodeling and the formation of both physical and molecular gradients, contributing to a malignant interactome and disease progression. [2] Among different ECM components, hyaluronan (HA)-a linear nonsulfated glycosaminoglycan, is an important player in cancer progression. [1,3] HA synthesis and degradation are tightly regulated, but in most tumors, including breast ones, HA homeostasis is altered, favoring the accumulation of HA fragments and oligosaccharides. [1b,3b,4] The generated fragments modulate the cell behavior of different cell populations within the tumor microenvironment by interaction with